175 related articles for article (PubMed ID: 21343932)
1. Expression of osteopontin coregulators in primary colorectal cancer and associated liver metastases.
Mole DJ; O'Neill C; Hamilton P; Olabi B; Robinson V; Williams L; Diamond T; El-Tanani M; Campbell FC
Br J Cancer; 2011 Mar; 104(6):1007-12. PubMed ID: 21343932
[TBL] [Abstract][Full Text] [Related]
2. Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells.
Konsavage WM; Kyler SL; Rennoll SA; Jin G; Yochum GS
J Biol Chem; 2012 Apr; 287(15):11730-9. PubMed ID: 22337891
[TBL] [Abstract][Full Text] [Related]
3. Ets gene PEA3 cooperates with beta-catenin-Lef-1 and c-Jun in regulation of osteopontin transcription.
El-Tanani M; Platt-Higgins A; Rudland PS; Campbell FC
J Biol Chem; 2004 May; 279(20):20794-806. PubMed ID: 14990565
[TBL] [Abstract][Full Text] [Related]
4. Wnt-β-catenin-Tcf-4 signalling-modulated invasiveness is dependent on osteopontin expression in breast cancer.
Ravindranath A; Yuen HF; Chan KK; Grills C; Fennell DA; Lappin TR; El-Tanani M
Br J Cancer; 2011 Aug; 105(4):542-51. PubMed ID: 21772333
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated stroma reveals prognostic biomarkers and novel insights into the tumour microenvironment of colorectal cancer and colorectal liver metastases.
Brown KM; Xue A; Smith RC; Samra JS; Gill AJ; Hugh TJ
Cancer Med; 2022 Jan; 11(2):492-506. PubMed ID: 34874125
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin-enhanced hepatic metastasis of colorectal cancer cells.
Huang J; Pan C; Hu H; Zheng S; Ding L
PLoS One; 2012; 7(10):e47901. PubMed ID: 23112867
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of the upregulated osteopontin mRNA expression in human colorectal cancer.
Likui W; Hong W; Shuwen Z
J Gastrointest Surg; 2010 Jan; 14(1):74-81. PubMed ID: 19763701
[TBL] [Abstract][Full Text] [Related]
8. Ets-1 and runx2 regulate transcription of a metastatic gene, osteopontin, in murine colorectal cancer cells.
Wai PY; Mi Z; Gao C; Guo H; Marroquin C; Kuo PC
J Biol Chem; 2006 Jul; 281(28):18973-82. PubMed ID: 16670084
[TBL] [Abstract][Full Text] [Related]
9. Relationship between osteopontin and β-catenin immunohistochemical expression and prognostic parameters of colorectal carcinoma.
Youssef NS; Osman WM
Int J Clin Exp Pathol; 2015; 8(2):1503-14. PubMed ID: 25973035
[TBL] [Abstract][Full Text] [Related]
10. Pea3 expression promotes the invasive and metastatic potential of colorectal carcinoma.
Mesci A; Taeb S; Huang X; Jairath R; Sivaloganathan D; Liu SK
World J Gastroenterol; 2014 Dec; 20(46):17376-87. PubMed ID: 25516649
[TBL] [Abstract][Full Text] [Related]
11. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.
Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS
Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031
[TBL] [Abstract][Full Text] [Related]
12. In vitro and clinical data analysis of Osteopontin as a prognostic indicator in colorectal cancer.
Wei R; Wong JPC; Lyu P; Xi X; Tong O; Zhang SD; Yuen HF; Shirasawa S; Kwok HF
J Cell Mol Med; 2018 Sep; 22(9):4097-4105. PubMed ID: 29851214
[TBL] [Abstract][Full Text] [Related]
13. Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma.
Zhao J; Lu B; Xu H; Tong X; Wu G; Zhang X; Liang A; Cong W; Dai J; Wang H; Wu M; Guo Y
Hepatology; 2008 Jul; 48(1):265-75. PubMed ID: 18537194
[TBL] [Abstract][Full Text] [Related]
14. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of beta-catenin in colorectal cancer with liver metastasis.
Han SA; Chun H; Park CM; Kang SJ; Kim SH; Sohn D; Yun SH; Lee WY
Clin Oncol (R Coll Radiol); 2006 Dec; 18(10):761-7. PubMed ID: 17168211
[TBL] [Abstract][Full Text] [Related]
16. Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker.
Lin AY; Chua MS; Choi YL; Yeh W; Kim YH; Azzi R; Adams GA; Sainani K; van de Rijn M; So SK; Pollack JR
PLoS One; 2011 Feb; 6(2):e16636. PubMed ID: 21383983
[TBL] [Abstract][Full Text] [Related]
17. USP22 drives colorectal cancer invasion and metastasis via epithelial-mesenchymal transition by activating AP4.
Li Y; Yang Y; Li J; Liu H; Chen F; Li B; Cui B; Liu Y
Oncotarget; 2017 May; 8(20):32683-32695. PubMed ID: 28427243
[TBL] [Abstract][Full Text] [Related]
18. ELR+ CXC chemokine expression in benign and malignant colorectal conditions.
Rubie C; Frick VO; Wagner M; Schuld J; Gräber S; Brittner B; Bohle RM; Schilling MK
BMC Cancer; 2008 Jun; 8():178. PubMed ID: 18578857
[TBL] [Abstract][Full Text] [Related]
19. Association of Osteopontin Gene Polymorphisms with Colorectal Cancer.
Kamal A; Darwish RK; Saad S; Salama M; El-Baradie TS; Mahmoud HG; Elshiwy Y
Cancer Invest; 2017 Feb; 35(2):71-77. PubMed ID: 28095066
[TBL] [Abstract][Full Text] [Related]
20. Disruption of clock gene expression in human colorectal liver metastases.
Huisman SA; Ahmadi AR; IJzermans JN; Verhoef C; van der Horst GT; de Bruin RW
Tumour Biol; 2016 Oct; 37(10):13973-13981. PubMed ID: 27492458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
